Polθ Inhibitor (ART558) Demonstrates a Synthetic Lethal Effect with PARP and RAD52 Inhibitors in Glioblastoma Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25179134 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Gabriela Barszczewska-Pietraszek und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, 90-236 Lodz, Poland. Hauptthemen laut MEDLINE: Glioblastoma, Rad52 DNA Repair and Recombination Protein, Poly(ADP-ribose) Polymerase Inhibitors, Temozolomide. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH/NCI, NCI NIH HHS, the Polish National Science Center.
Abstract (Originalsprache)
DNA repair proteins became the popular targets in research on cancer treatment. In our studies we hypothesized that inhibition of DNA polymerase theta (Polθ) and its combination with Poly (ADP-ribose) polymerase 1 (PARP1) or RAD52 inhibition and the alkylating drug temozolomide (TMZ) has an anticancer effect on glioblastoma cells (GBM21), whereas it has a low impact on normal human astrocytes (NHA). The effect of the compounds was assessed by analysis of cell viability, apoptosis, proliferation, DNA damage and cell cycle distribution, as well as gene expression. The main results show that Polθ inhibition causes a significant decrease in glioblastoma cell viability. It induces apoptosis, which is accompanied by a reduction in cell proliferation and DNA damage. Moreover, the effect was stronger when dual inhibition of Polθ with PARP1 or RAD52 was applied, and it is further enhanced by addition of TMZ. The impact on normal cells is much lower, especially when considering cell viability and DNA damage. In conclusion, we would like to highlight that Polθ inhibition used in combination with PARP1 or RAD52 inhibition has great potential to kill glioblastoma cells, and shows a synthetic lethal effect, while sparing normal astrocytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, 90-236 Lodz, Poland.
- Department of Medical Biochemistry, Medical University of Lodz, 92-216 Lodz, Poland.
- Department of Neurosurgery, Surgery of Spine and Peripheral Nerves, Medical University of Lodz, University Hospital WAM-CSW, 90-549 Lodz, Poland.
- Department of Medical Biology, Medical University of Lodz, 92-151 Lodz, Poland.
- Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
ORCID-Profile: Gabriela Barszczewska-Pietraszek, Piotr Czarny, Małgorzata Drzewiecka, Maciej Radek, Przemysław Sitarek, Janusz Szemraj, Tomasz Śliwiński
Förderung
- NIH/NCI
- NCI NIH HHS
- the Polish National Science Center
Zitieren
APA
Barszczewska-Pietraszek, G., Czarny, P., Drzewiecka, M., Błaszczyk, M., Radek, M., Synowiec, E., Wigner-Jeziorska, P., Sitarek, P., Szemraj, J., Skorski, T., & Śliwiński, T. (2024). Polθ Inhibitor (ART558) Demonstrates a Synthetic Lethal Effect with PARP and RAD52 Inhibitors in Glioblastoma Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179134
Vancouver
Barszczewska-Pietraszek G, Czarny P, Drzewiecka M, Błaszczyk M, Radek M, Synowiec E, et al. Polθ Inhibitor (ART558) Demonstrates a Synthetic Lethal Effect with PARP and RAD52 Inhibitors in Glioblastoma Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179134
BibTeX
@article{BarszczewskaPietraszek2024,
author = {Barszczewska-Pietraszek, Gabriela and Czarny, Piotr and Drzewiecka, Małgorzata and Błaszczyk, Maciej and Radek, Maciej and Synowiec, Ewelina and Wigner-Jeziorska, Paulina and Sitarek, Przemysław and Szemraj, Janusz and Skorski, Tomasz and Śliwiński, Tomasz},
title = {Polθ Inhibitor (ART558) Demonstrates a Synthetic Lethal Effect with PARP and RAD52 Inhibitors in Glioblastoma Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25179134}
}
EUVIMED